Quickly Spot Consensus Among the World’s Best Equity Analysts
| Name | Upside % |
Analysts bullish % |
|
|---|---|---|---|
|
109%
upside
6 price targets
|
0
%
|
|
|
|
108%
upside
5 price targets
|
0
%
|
|
|
|
104%
upside
3 price targets
|
0
%
|
|
|
54
Lexeo Therapeutics
LXEO
$712M
|
103%
upside
5 price targets
|
0
%
|
|
|
102%
upside
3 price targets
|
0
%
|
|
|
|
101%
upside
3 price targets
|
0
%
|
|
|
|
101%
upside
4 price targets
|
0
%
|
|
|
|
100%
upside
4 price targets
|
0
%
|
|
|
|
98%
upside
5 price targets
|
0
%
|
|
|
|
98%
upside
4 price targets
|
0
%
|
|
|
|
NBP
61
NovaBridge Biosciences American Depositary Shares
NBP
$469M
|
97%
upside
3 price targets
|
0
%
|
|
|
95%
upside
5 price targets
|
0
%
|
|
|
|
92%
upside
4 price targets
|
0
%
|
|
|
|
92%
upside
4 price targets
|
0
%
|
|
|
|
91%
upside
5 price targets
|
0
%
|
|
|
|
89%
upside
4 price targets
|
0
%
|
|
|
|
86%
upside
3 price targets
|
0
%
|
|
|
|
84%
upside
7 price targets
|
0
%
|
|
|
|
82%
upside
7 price targets
|
0
%
|
|
|
|
82%
upside
10 price targets
|
0
%
|
|
|
|
81%
upside
3 price targets
|
0
%
|
|
|
|
79%
upside
6 price targets
|
0
%
|
|
|
|
79%
upside
3 price targets
|
0
%
|
|
|
|
78%
upside
4 price targets
|
0
%
|
|
|
|
78%
upside
3 price targets
|
0
%
|
|